Bioterrorism Assay Expedited Review Backed By House Med Tech Caucus

Roche will submit an investigational device exemption to FDA the week of Nov. 19 for a one-hour anthrax assay developed in collaboration with the Mayo Clinic

More from Archive

More from Medtech Insight